Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.

Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.

Item
http://www.wikidata.org/entity/Q34077023
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsCytomegalovirus infection in transplant recipientsLong-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies.Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.Use of leflunomide in renal transplant recipients with ganciclovir-resistant/refractory cytomegalovirus infection: a case series from the University of Chicago.Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.Syndrome of rapid-onset end-stage renal disease in two consecutive renal transplant recipients.Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.Immune response to CMV in solid organ transplant recipients: current concepts and future directions.Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients.The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.High human cytomegalovirus DNAemia early post-transplantation associates with irreversible and progressive loss of renal function - a retrospective study.Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation.
P2860

Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.

Item
http://www.wikidata.org/entity/Q34077023
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of prophylactic versus ...... term renal allograft outcomes.
@ast
Impact of prophylactic versus ...... term renal allograft outcomes.
@en
Impact of prophylactic versus ...... term renal allograft outcomes.
@nl
type
label
Impact of prophylactic versus ...... term renal allograft outcomes.
@ast
Impact of prophylactic versus ...... term renal allograft outcomes.
@en
Impact of prophylactic versus ...... term renal allograft outcomes.
@nl
prefLabel
Impact of prophylactic versus ...... term renal allograft outcomes.
@ast
Impact of prophylactic versus ...... term renal allograft outcomes.
@en
Impact of prophylactic versus ...... term renal allograft outcomes.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Impact of prophylactic versus ...... term renal allograft outcomes.
@en
P2093
P2860
P304
P31
P356
10.1097/TP.0B013E3181E81AFC
P433
P478
P577
P698
P932